Clinical Trials in Pittsburgh

Showing 10261-10280 of 21,047 trials

A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)

NCT03205163

The primary purpose was to assess the safety and tolerability of a single intravenous (IV) administration of BIVV001 in adult previously treated patients (PTPs) with severe hemophilia A.

Hemophilia A

Bioverativ, a Sanofi company16 participantsStarted Aug 2017

Los Angeles, California, United States • Indianapolis, Indiana, United States • Iowa City, Iowa, United States +7 more locations

COMPLETEDPhase 3< 1 mile

A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)

NCT01721746

The purpose of the study is to estimate the response rate and compare overall survival of patients taking BMS-936558 to those taking study physician's choice of either Dacarbazine or Carboplatin and Paclitaxel

Unresectable or Metastatic Melanoma

Bristol-Myers Squibb405 participantsStarted Dec 2012

Phoenix, Arizona, United States • La Jolla, California, United States • Los Angeles, California, United States +92 more locations

A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)

A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)

Find Trials by Condition in Pittsburgh

The Product Surveillance Registry REVERSE Post Approval Study

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Low-Level Laser Therapy for Prevention of Oral Mucositis

Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer

Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

Supported Employment Demonstration

CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma

An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials

A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes

Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome

SMS Maama Project COVID-19

Immunogenicity and Safety of a Purified Vero Rabies Vaccine

Revealed Versus Concealed Cerebroplacental Ratio